date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.554956548473628.
The log-likelihood improved by 3.475.
Iteration 2 of at most 500:
Optimizing with step length 0.914297716450118.
The log-likelihood improved by 2.164.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5036.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.08668.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       11     1288     1079      795      326      371      330 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     284      210      139       84       41       24        9        6 
degree16 degree18 
       1        1 
1 
disease_progression 
H-positive risk:  830 891 123 857 449 122 898 437 127 64 137 65 
H-negative risk:  891 830 898 857 437 449 122 123 137 127 65 64 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
62 new agents 
2 
disease_progression 
H-positive risk:  832 895 122 855 446 122 905 430 126 62 140 65 
H-negative risk:  895 832 905 855 430 446 122 122 140 126 65 62 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
3 
disease_progression 
H-positive risk:  834 899 124 855 448 124 900 423 127 63 139 64 
H-negative risk:  899 834 900 855 423 448 124 124 139 127 64 63 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
48 new agents 
4 
disease_progression 
H-positive risk:  837 902 123 857 448 124 897 421 125 64 140 62 
H-negative risk:  902 837 897 857 421 448 124 123 140 125 62 64 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 6 

clinical_engagement 
diagnosis 
demography 
64 new agents 
5 
disease_progression 
H-positive risk:  846 910 121 847 448 124 894 421 128 62 136 63 
H-negative risk:  910 846 894 847 421 448 124 121 136 128 63 62 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 6 

clinical_engagement 
diagnosis 
demography 
61 new agents 
6 
disease_progression 
H-positive risk:  852 910 123 847 446 126 895 416 124 62 137 62 
H-negative risk:  910 852 895 847 416 446 126 123 137 124 62 62 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
7 
disease_progression 
H-positive risk:  856 912 122 848 446 125 898 409 124 61 138 61 
H-negative risk:  912 856 898 848 409 446 125 122 138 124 61 61 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 9 

clinical_engagement 
diagnosis 
demography 
51 new agents 
8 
disease_progression 
H-positive risk:  860 915 124 850 438 126 898 406 123 61 138 61 
H-negative risk:  915 860 898 850 406 438 126 124 138 123 61 61 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 11 

clinical_engagement 
diagnosis 
demography 
58 new agents 
9 
disease_progression 
H-positive risk:  870 922 128 845 426 127 902 400 122 59 138 61 
H-negative risk:  922 870 902 845 400 426 127 128 138 122 61 59 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 13 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
10 
disease_progression 
H-positive risk:  872 925 130 846 416 129 901 400 125 57 139 60 
H-negative risk:  925 872 901 846 400 416 129 130 139 125 60 57 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 14 3 

clinical_engagement 
diagnosis 
demography 
66 new agents 
11 
disease_progression 
H-positive risk:  879 929 132 843 411 130 896 399 126 56 138 61 
H-negative risk:  929 879 896 843 399 411 130 132 138 126 61 56 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 20 4 

clinical_engagement 
diagnosis 
demography 
74 new agents 
12 
disease_progression 
H-positive risk:  888 929 133 844 408 132 895 392 128 54 137 60 
H-negative risk:  929 888 895 844 392 408 132 133 137 128 60 54 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 20 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
13 
disease_progression 
H-positive risk:  825 857 127 923 402 122 968 390 135 54 140 57 
H-negative risk:  857 825 968 923 390 402 122 127 140 135 57 54 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 25 4 

clinical_engagement 
diagnosis 
demography 
216 new agents 
14 
disease_progression 
H-positive risk:  854 888 132 882 417 126 907 408 127 60 131 68 
H-negative risk:  888 854 907 882 408 417 126 132 131 127 68 60 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 26 5 

clinical_engagement 
diagnosis 
demography 
63 new agents 
15 
disease_progression 
H-positive risk:  856 895 131 880 412 125 910 400 130 61 134 66 
H-negative risk:  895 856 910 880 400 412 125 131 134 130 66 61 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 25 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
16 
disease_progression 
H-positive risk:  862 899 132 875 406 125 909 402 129 62 132 67 
H-negative risk:  899 862 909 875 402 406 125 132 132 129 67 62 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 28 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
17 
disease_progression 
H-positive risk:  856 906 131 870 404 128 908 402 130 62 134 69 
H-negative risk:  906 856 908 870 402 404 128 131 134 130 69 62 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
18 
disease_progression 
H-positive risk:  867 903 131 872 396 130 910 400 130 59 137 65 
H-negative risk:  903 867 910 872 400 396 130 131 137 130 65 59 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
57 new agents 
19 
disease_progression 
H-positive risk:  866 913 131 865 391 131 917 395 130 61 135 65 
H-negative risk:  913 866 917 865 395 391 131 131 135 130 65 61 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 29 8 

clinical_engagement 
diagnosis 
demography 
65 new agents 
20 
disease_progression 
H-positive risk:  873 927 131 859 385 132 914 391 131 57 134 66 
H-negative risk:  927 873 914 859 391 385 132 131 134 131 66 57 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 29 9 

clinical_engagement 
diagnosis 
demography 
67 new agents 
21 
disease_progression 
H-positive risk:  882 930 132 852 387 131 908 393 128 58 134 65 
H-negative risk:  930 882 908 852 393 387 131 132 134 128 65 58 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 29 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
22 
disease_progression 
H-positive risk:  891 934 133 849 380 130 914 389 129 57 130 64 
H-negative risk:  934 891 914 849 389 380 130 133 130 129 64 57 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 31 11 

clinical_engagement 
diagnosis 
demography 
60 new agents 
23 
disease_progression 
H-positive risk:  898 938 133 842 377 130 917 387 126 55 134 63 
H-negative risk:  938 898 917 842 387 377 130 133 134 126 63 55 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 32 12 

clinical_engagement 
diagnosis 
demography 
54 new agents 
24 
disease_progression 
H-positive risk:  904 937 133 841 378 132 914 382 126 54 137 62 
H-negative risk:  937 904 914 841 382 378 132 133 137 126 62 54 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
64 new agents 
25 
disease_progression 
H-positive risk:  867 854 126 919 381 123 958 373 135 56 143 65 
H-negative risk:  854 867 958 919 373 381 123 126 143 135 65 56 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
174 new agents 
26 
disease_progression 
H-positive risk:  892 873 132 882 388 125 919 394 127 66 131 71 
H-negative risk:  873 892 919 882 394 388 125 132 131 127 71 66 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 39 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
27 
disease_progression 
H-positive risk:  893 874 131 892 378 127 911 396 126 68 134 70 
H-negative risk:  874 893 911 892 396 378 127 131 134 126 70 68 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 40 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
28 
disease_progression 
H-positive risk:  894 883 130 889 373 128 911 392 129 68 131 72 
H-negative risk:  883 894 911 889 392 373 128 130 131 129 72 68 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 41 12 

clinical_engagement 
diagnosis 
demography 
43 new agents 
29 
disease_progression 
H-positive risk:  894 885 129 891 367 126 915 393 129 69 129 73 
H-negative risk:  885 894 915 891 393 367 126 129 129 129 73 69 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 41 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
30 
disease_progression 
H-positive risk:  897 897 130 892 364 124 907 394 128 68 128 71 
H-negative risk:  897 897 907 892 394 364 124 130 128 128 71 68 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 43 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
31 
disease_progression 
H-positive risk:  900 898 130 903 354 124 904 396 129 66 126 70 
H-negative risk:  898 900 904 903 396 354 124 130 126 129 70 66 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 45 12 

clinical_engagement 
diagnosis 
demography 
57 new agents 
32 
disease_progression 
H-positive risk:  902 900 129 906 350 124 911 392 128 63 128 67 
H-negative risk:  900 902 911 906 392 350 124 129 128 128 67 63 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 43 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
33 
disease_progression 
H-positive risk:  904 906 128 908 346 124 911 388 129 62 126 68 
H-negative risk:  906 904 911 908 388 346 124 128 126 129 68 62 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 42 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
34 
disease_progression 
H-positive risk:  911 914 131 897 347 121 910 383 132 60 125 69 
H-negative risk:  914 911 910 897 383 347 121 131 125 132 69 60 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 44 11 

clinical_engagement 
diagnosis 
demography 
60 new agents 
35 
disease_progression 
H-positive risk:  910 920 133 896 348 118 919 372 132 57 126 69 
H-negative risk:  920 910 919 896 372 348 118 133 126 132 69 57 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 47 11 

clinical_engagement 
diagnosis 
demography 
48 new agents 
36 
disease_progression 
H-positive risk:  914 911 134 897 347 118 920 377 133 55 125 69 
H-negative risk:  911 914 920 897 377 347 118 134 125 133 69 55 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 47 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
37 
disease_progression 
H-positive risk:  850 860 121 947 345 109 992 372 142 54 136 72 
H-negative risk:  860 850 992 947 372 345 109 121 136 142 72 54 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 44 12 

clinical_engagement 
diagnosis 
demography 
129 new agents 
38 
disease_progression 
H-positive risk:  867 871 124 909 364 112 948 406 139 57 134 69 
H-negative risk:  871 867 948 909 406 364 112 124 134 139 69 57 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 49 12 

clinical_engagement 
diagnosis 
demography 
85 new agents 
39 
disease_progression 
H-positive risk:  874 882 126 898 363 111 948 403 140 56 131 68 
H-negative risk:  882 874 948 898 403 363 111 126 131 140 68 56 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
40 
disease_progression 
H-positive risk:  873 890 124 909 356 111 945 397 140 57 129 69 
H-negative risk:  890 873 945 909 397 356 111 124 129 140 69 57 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
41 
disease_progression 
H-positive risk:  884 899 124 901 354 112 942 396 138 57 127 66 
H-negative risk:  899 884 942 901 396 354 112 124 127 138 66 57 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 52 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
42 
disease_progression 
H-positive risk:  893 901 125 903 345 112 944 387 139 58 127 66 
H-negative risk:  901 893 944 903 387 345 112 125 127 139 66 58 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 53 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
43 
disease_progression 
H-positive risk:  896 901 123 902 337 113 951 388 137 58 128 66 
H-negative risk:  901 896 951 902 388 337 113 123 128 137 66 58 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 54 11 

clinical_engagement 
diagnosis 
demography 
46 new agents 
44 
disease_progression 
H-positive risk:  902 906 122 905 332 114 944 389 137 56 128 65 
H-negative risk:  906 902 944 905 389 332 114 122 128 137 65 56 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 55 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
45 
disease_progression 
H-positive risk:  904 908 122 905 336 114 943 384 138 55 130 61 
H-negative risk:  908 904 943 905 384 336 114 122 130 138 61 55 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 58 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
46 
disease_progression 
H-positive risk:  904 916 124 905 329 115 944 383 139 55 125 61 
H-negative risk:  916 904 944 905 383 329 115 124 125 139 61 55 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 55 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  904 910 124 906 332 116 949 386 138 55 121 59 
H-negative risk:  910 904 949 906 386 332 116 124 121 138 59 55 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 55 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
48 
disease_progression 
H-positive risk:  908 917 124 898 332 117 947 382 138 55 120 62 
H-negative risk:  917 908 947 898 382 332 117 124 120 138 62 55 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 54 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
49 
disease_progression 
H-positive risk:  845 862 115 961 335 110 1010 377 144 54 127 60 
H-negative risk:  862 845 1010 961 377 335 110 115 127 144 60 54 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 58 12 

clinical_engagement 
diagnosis 
demography 
128 new agents 
50 
disease_progression 
H-positive risk:  857 871 117 933 364 109 991 378 142 56 120 62 
H-negative risk:  871 857 991 933 378 364 109 117 120 142 62 56 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 57 11 

clinical_engagement 
diagnosis 
demography 
73 new agents 
51 
disease_progression 
H-positive risk:  861 875 115 927 372 109 989 379 142 51 120 60 
H-negative risk:  875 861 989 927 379 372 109 115 120 142 60 51 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 56 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  869 877 116 925 373 109 986 374 139 52 122 58 
H-negative risk:  877 869 986 925 374 373 109 116 122 139 58 52 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 55 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
53 
disease_progression 
H-positive risk:  871 876 116 922 374 110 983 374 137 55 122 60 
H-negative risk:  876 871 983 922 374 374 110 116 122 137 60 55 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  872 881 117 916 373 109 987 372 139 54 124 56 
H-negative risk:  881 872 987 916 372 373 109 117 124 139 56 54 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
55 
disease_progression 
H-positive risk:  882 883 118 919 367 108 979 374 139 52 124 55 
H-negative risk:  883 882 979 919 374 367 108 118 124 139 55 52 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
56 
disease_progression 
H-positive risk:  894 881 120 922 362 108 976 369 136 54 122 56 
H-negative risk:  881 894 976 922 369 362 108 120 122 136 56 54 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
57 
disease_progression 
H-positive risk:  889 883 120 931 358 107 984 358 135 55 123 57 
H-negative risk:  883 889 984 931 358 358 107 120 123 135 57 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
68 new agents 
58 
disease_progression 
H-positive risk:  894 874 118 931 358 110 985 358 136 56 124 56 
H-negative risk:  874 894 985 931 358 358 110 118 124 136 56 56 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
59 
disease_progression 
H-positive risk:  890 871 118 934 359 112 991 359 132 56 123 55 
H-negative risk:  871 890 991 934 359 359 112 118 123 132 55 56 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
60 
disease_progression 
H-positive risk:  891 871 120 929 363 113 988 358 132 56 123 56 
H-negative risk:  871 891 988 929 358 363 113 120 123 132 56 56 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
55 new agents 
61 
disease_progression 
H-positive risk:  841 824 108 979 362 102 1039 357 139 57 137 55 
H-negative risk:  824 841 1039 979 357 362 102 108 137 139 55 57 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 54 12 

clinical_engagement 
diagnosis 
demography 
132 new agents 
62 
disease_progression 
H-positive risk:  854 831 108 976 353 104 1021 372 136 58 131 56 
H-negative risk:  831 854 1021 976 372 353 104 108 131 136 56 58 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 54 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
63 
disease_progression 
H-positive risk:  856 834 107 972 355 104 1015 372 138 57 131 59 
H-negative risk:  834 856 1015 972 372 355 104 107 131 138 59 57 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 52 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
64 
disease_progression 
H-positive risk:  854 829 109 974 360 101 1011 373 139 58 131 61 
H-negative risk:  829 854 1011 974 373 360 101 109 131 139 61 58 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
65 
disease_progression 
H-positive risk:  849 834 109 981 356 99 1017 366 141 57 132 59 
H-negative risk:  834 849 1017 981 366 356 99 109 132 141 59 57 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 55 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
66 
disease_progression 
H-positive risk:  855 841 109 977 350 100 1016 364 145 57 128 58 
H-negative risk:  841 855 1016 977 364 350 100 109 128 145 58 57 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 55 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
67 
disease_progression 
H-positive risk:  863 840 110 971 350 104 1016 362 145 55 130 54 
H-negative risk:  840 863 1016 971 362 350 104 110 130 145 54 55 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 57 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
68 
disease_progression 
H-positive risk:  863 847 109 972 356 105 1009 364 144 51 127 53 
H-negative risk:  847 863 1009 972 364 356 105 109 127 144 53 51 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 56 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
69 
disease_progression 
H-positive risk:  854 852 111 974 356 103 1005 367 143 52 131 52 
H-negative risk:  852 854 1005 974 367 356 103 111 131 143 52 52 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 58 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
70 
disease_progression 
H-positive risk:  853 852 112 970 353 105 1004 374 142 53 130 52 
H-negative risk:  852 853 1004 970 374 353 105 112 130 142 52 53 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 60 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
71 
disease_progression 
H-positive risk:  853 855 112 979 353 105 1001 368 138 53 133 50 
H-negative risk:  855 853 1001 979 368 353 105 112 133 138 50 53 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 61 11 

clinical_engagement 
diagnosis 
demography 
79 new agents 
72 
disease_progression 
H-positive risk:  861 859 113 985 349 105 995 364 135 52 133 49 
H-negative risk:  859 861 995 985 364 349 105 113 133 135 49 52 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 60 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
73 
disease_progression 
H-positive risk:  818 792 104 1052 347 97 1034 364 146 51 144 51 
H-negative risk:  792 818 1034 1052 364 347 97 104 144 146 51 51 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 60 14 

clinical_engagement 
diagnosis 
demography 
131 new agents 
74 
disease_progression 
H-positive risk:  812 807 104 1037 361 96 1033 366 143 50 142 49 
H-negative risk:  807 812 1033 1037 366 361 96 104 142 143 49 50 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 57 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
75 
disease_progression 
H-positive risk:  808 805 105 1030 364 101 1035 367 141 52 142 50 
H-negative risk:  805 808 1035 1030 367 364 101 105 142 141 50 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
76 
disease_progression 
H-positive risk:  811 805 107 1036 353 103 1045 358 137 54 142 49 
H-negative risk:  805 811 1045 1036 358 353 103 107 142 137 49 54 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 61 11 

clinical_engagement 
diagnosis 
demography 
75 new agents 
77 
disease_progression 
H-positive risk:  816 807 110 1039 346 104 1040 358 135 55 141 49 
H-negative risk:  807 816 1040 1039 358 346 104 110 141 135 49 55 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 60 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
78 
disease_progression 
H-positive risk:  820 817 106 1043 342 103 1037 349 137 53 146 47 
H-negative risk:  817 820 1037 1043 349 342 103 106 146 137 47 53 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 56 12 

clinical_engagement 
diagnosis 
demography 
50 new agents 
79 
disease_progression 
H-positive risk:  813 811 108 1039 353 105 1044 347 136 54 143 47 
H-negative risk:  811 813 1044 1039 347 353 105 108 143 136 47 54 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 58 13 

clinical_engagement 
diagnosis 
demography 
90 new agents 
80 
disease_progression 
H-positive risk:  822 807 108 1027 358 107 1037 349 137 53 148 47 
H-negative risk:  807 822 1037 1027 349 358 107 108 148 137 47 53 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 56 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
81 
disease_progression 
H-positive risk:  822 800 110 1028 356 108 1042 354 135 51 147 47 
H-negative risk:  800 822 1042 1028 354 356 108 110 147 135 47 51 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 57 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
82 
disease_progression 
H-positive risk:  828 800 110 1029 353 109 1043 354 132 50 146 46 
H-negative risk:  800 828 1043 1029 354 353 109 110 146 132 46 50 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 57 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
83 
disease_progression 
H-positive risk:  828 799 109 1035 354 107 1037 353 134 51 148 45 
H-negative risk:  799 828 1037 1035 353 354 107 109 148 134 45 51 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 54 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
84 
disease_progression 
H-positive risk:  835 798 110 1036 349 106 1040 351 134 48 147 46 
H-negative risk:  798 835 1040 1036 351 349 106 110 147 134 46 48 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
89 new agents 
85 
disease_progression 
H-positive risk:  784 746 107 1088 349 97 1098 348 139 48 151 45 
H-negative risk:  746 784 1098 1088 348 349 97 107 151 139 45 48 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
110 new agents 
86 
disease_progression 
H-positive risk:  790 749 106 1067 375 96 1076 360 145 45 150 41 
H-negative risk:  749 790 1076 1067 360 375 96 106 150 145 41 45 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
87 
disease_progression 
H-positive risk:  792 747 105 1059 374 97 1075 367 146 48 149 41 
H-negative risk:  747 792 1075 1059 367 374 97 105 149 146 41 48 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 60 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
88 
disease_progression 
H-positive risk:  789 752 107 1054 371 98 1073 373 143 50 150 40 
H-negative risk:  752 789 1073 1054 373 371 98 107 150 143 40 50 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 59 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
89 
disease_progression 
H-positive risk:  786 745 111 1056 374 99 1075 371 145 49 148 41 
H-negative risk:  745 786 1075 1056 371 374 99 111 148 145 41 49 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 61 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
90 
disease_progression 
H-positive risk:  786 748 108 1050 377 101 1073 377 143 48 145 44 
H-negative risk:  748 786 1073 1050 377 377 101 108 145 143 44 48 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 65 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
91 
disease_progression 
H-positive risk:  786 748 111 1043 373 100 1080 373 146 48 147 45 
H-negative risk:  748 786 1080 1043 373 373 100 111 147 146 45 48 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 67 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
92 
disease_progression 
H-positive risk:  781 743 112 1046 375 101 1081 373 147 48 146 47 
H-negative risk:  743 781 1081 1046 373 375 101 112 146 147 47 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
93 
disease_progression 
H-positive risk:  784 735 112 1047 380 101 1083 369 145 48 148 48 
H-negative risk:  735 784 1083 1047 369 380 101 112 148 145 48 48 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
94 
disease_progression 
H-positive risk:  783 734 112 1056 379 100 1078 367 147 46 147 51 
H-negative risk:  734 783 1078 1056 367 379 100 112 147 147 51 46 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
95 
disease_progression 
H-positive risk:  788 740 110 1065 381 100 1062 364 145 48 146 51 
H-negative risk:  740 788 1062 1065 364 381 100 110 146 145 51 48 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
96 
disease_progression 
H-positive risk:  787 740 111 1064 383 98 1057 363 145 49 149 54 
H-negative risk:  740 787 1057 1064 363 383 98 111 149 145 54 49 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
90 new agents 
97 
disease_progression 
H-positive risk:  747 712 104 1095 384 88 1088 367 149 53 159 54 
H-negative risk:  712 747 1088 1095 367 384 88 104 159 149 54 53 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
107 new agents 
98 
disease_progression 
H-positive risk:  742 712 105 1080 393 90 1089 374 146 56 156 57 
H-negative risk:  712 742 1089 1080 374 393 90 105 156 146 57 56 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
83 new agents 
99 
disease_progression 
H-positive risk:  743 711 103 1087 393 90 1081 374 146 57 159 56 
H-negative risk:  711 743 1081 1087 374 393 90 103 159 146 56 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
100 
disease_progression 
H-positive risk:  740 708 105 1094 389 92 1087 372 144 57 156 56 
H-negative risk:  708 740 1087 1094 372 389 92 105 156 144 56 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
101 
disease_progression 
H-positive risk:  749 703 104 1103 385 95 1084 367 146 55 154 55 
H-negative risk:  703 749 1084 1103 367 385 95 104 154 146 55 55 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
102 
disease_progression 
H-positive risk:  758 698 103 1103 378 94 1080 373 148 54 157 54 
H-negative risk:  698 758 1080 1103 373 378 94 103 157 148 54 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
103 
disease_progression 
H-positive risk:  763 703 104 1100 384 90 1076 370 149 54 152 55 
H-negative risk:  703 763 1076 1100 370 384 90 104 152 149 55 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
54 new agents 
104 
disease_progression 
H-positive risk:  757 706 103 1099 380 91 1078 377 150 53 151 55 
H-negative risk:  706 757 1078 1099 377 380 91 103 151 150 55 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
105 
disease_progression 
H-positive risk:  761 699 101 1097 376 92 1079 383 149 55 153 55 
H-negative risk:  699 761 1079 1097 383 376 92 101 153 149 55 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
106 
disease_progression 
H-positive risk:  756 691 103 1101 380 93 1074 391 152 54 151 54 
H-negative risk:  691 756 1074 1101 391 380 93 103 151 152 54 54 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 71 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
107 
disease_progression 
H-positive risk:  753 695 101 1103 378 92 1078 389 149 53 156 53 
H-negative risk:  695 753 1078 1103 389 378 92 101 156 149 53 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
62 new agents 
108 
disease_progression 
H-positive risk:  753 700 102 1099 384 89 1075 389 148 53 157 51 
H-negative risk:  700 753 1075 1099 389 384 89 102 157 148 51 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 70 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
109 
disease_progression 
H-positive risk:  711 646 96 1152 373 83 1122 399 151 55 161 51 
H-negative risk:  646 711 1122 1152 399 373 83 96 161 151 51 55 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 66 12 

clinical_engagement 
diagnosis 
demography 
107 new agents 
110 
disease_progression 
H-positive risk:  720 633 95 1153 374 81 1106 416 152 55 165 50 
H-negative risk:  633 720 1106 1153 416 374 81 95 165 152 50 55 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 66 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
111 
disease_progression 
H-positive risk:  728 630 92 1158 369 81 1102 414 155 55 163 53 
H-negative risk:  630 728 1102 1158 414 369 81 92 163 155 53 55 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 66 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
112 
disease_progression 
H-positive risk:  729 633 94 1154 364 82 1111 413 151 58 155 56 
H-negative risk:  633 729 1111 1154 413 364 82 94 155 151 56 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
113 
disease_progression 
H-positive risk:  731 640 94 1143 373 81 1111 406 151 59 150 61 
H-negative risk:  640 731 1111 1143 406 373 81 94 150 151 61 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
114 
disease_progression 
H-positive risk:  733 641 94 1132 378 80 1114 405 155 58 150 60 
H-negative risk:  641 733 1114 1132 405 378 80 94 150 155 60 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
115 
disease_progression 
H-positive risk:  737 643 93 1129 386 79 1109 397 155 59 151 62 
H-negative risk:  643 737 1109 1129 397 386 79 93 151 155 62 59 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
116 
disease_progression 
H-positive risk:  740 646 94 1131 378 76 1106 402 159 57 152 59 
H-negative risk:  646 740 1106 1131 402 378 76 94 152 159 59 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
117 
disease_progression 
H-positive risk:  736 658 94 1126 382 75 1101 404 158 57 150 59 
H-negative risk:  658 736 1101 1126 404 382 75 94 150 158 59 57 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
118 
disease_progression 
H-positive risk:  735 652 96 1126 385 77 1100 409 157 54 146 63 
H-negative risk:  652 735 1100 1126 409 385 77 96 146 157 63 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
119 
disease_progression 
H-positive risk:  744 652 98 1120 390 80 1085 415 153 56 146 61 
H-negative risk:  652 744 1085 1120 415 390 80 98 146 153 61 56 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
120 
disease_progression 
H-positive risk:  748 650 100 1123 383 79 1090 411 151 58 147 60 
H-negative risk:  650 748 1090 1123 411 383 79 100 147 151 60 58 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
121 
disease_progression 
H-positive risk:  702 611 93 1157 387 79 1130 412 159 56 152 62 
H-negative risk:  611 702 1130 1157 412 387 79 93 152 159 62 56 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
122 
disease_progression 
H-positive risk:  688 610 94 1141 409 77 1133 417 156 61 152 62 
H-negative risk:  610 688 1133 1141 417 409 77 94 152 156 62 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
123 
disease_progression 
H-positive risk:  690 615 95 1139 407 79 1129 420 156 60 149 61 
H-negative risk:  615 690 1129 1139 420 407 79 95 149 156 61 60 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
124 
disease_progression 
H-positive risk:  696 626 95 1129 398 82 1130 417 155 62 148 62 
H-negative risk:  626 696 1130 1129 417 398 82 95 148 155 62 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
125 
disease_progression 
H-positive risk:  702 627 97 1128 400 79 1132 413 154 62 144 62 
H-negative risk:  627 702 1132 1128 413 400 79 97 144 154 62 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
126 
disease_progression 
H-positive risk:  702 625 97 1124 401 79 1136 414 153 64 146 59 
H-negative risk:  625 702 1136 1124 414 401 79 97 146 153 59 64 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
127 
disease_progression 
H-positive risk:  703 616 99 1128 403 80 1136 409 156 65 147 58 
H-negative risk:  616 703 1136 1128 409 403 80 99 147 156 58 65 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
128 
disease_progression 
H-positive risk:  708 620 100 1114 406 81 1135 411 157 63 147 58 
H-negative risk:  620 708 1135 1114 411 406 81 100 147 157 58 63 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 71 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
129 
disease_progression 
H-positive risk:  705 623 99 1121 405 81 1133 406 157 62 150 58 
H-negative risk:  623 705 1133 1121 406 405 81 99 150 157 58 62 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
130 
disease_progression 
H-positive risk:  710 629 98 1115 400 81 1128 413 156 63 152 55 
H-negative risk:  629 710 1128 1115 413 400 81 98 152 156 55 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
131 
disease_progression 
H-positive risk:  700 636 96 1114 398 82 1132 415 157 62 153 55 
H-negative risk:  636 700 1132 1114 415 398 82 96 153 157 55 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  699 639 97 1108 402 81 1133 412 155 62 157 55 
H-negative risk:  639 699 1133 1108 412 402 81 97 157 155 55 62 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
133 
disease_progression 
H-positive risk:  694 643 99 1113 395 78 1137 409 155 64 158 55 
H-negative risk:  643 694 1137 1113 409 395 78 99 158 155 55 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
100 new agents 
134 
disease_progression 
H-positive risk:  693 637 101 1107 412 81 1129 415 152 65 151 57 
H-negative risk:  637 693 1129 1107 415 412 81 101 151 152 57 65 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 78 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
135 
disease_progression 
H-positive risk:  694 637 104 1106 414 84 1129 409 152 66 148 57 
H-negative risk:  637 694 1129 1106 409 414 84 104 148 152 57 66 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
92 new agents 
136 
disease_progression 
H-positive risk:  694 645 104 1106 408 83 1131 406 152 67 145 59 
H-negative risk:  645 694 1131 1106 406 408 83 104 145 152 59 67 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 78 14 

clinical_engagement 
diagnosis 
demography 
84 new agents 
137 
disease_progression 
H-positive risk:  688 651 102 1107 409 84 1139 402 151 67 144 56 
H-negative risk:  651 688 1139 1107 402 409 84 102 144 151 56 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
138 
disease_progression 
H-positive risk:  676 658 104 1099 405 85 1154 406 151 66 141 55 
H-negative risk:  658 676 1154 1099 406 405 85 104 141 151 55 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
139 
disease_progression 
H-positive risk:  673 659 107 1100 405 86 1152 408 150 66 140 54 
H-negative risk:  659 673 1152 1100 408 405 86 107 140 150 54 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
140 
disease_progression 
H-positive risk:  671 662 108 1108 395 85 1154 407 147 64 144 55 
H-negative risk:  662 671 1154 1108 407 395 85 108 144 147 55 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
89 new agents 
141 
disease_progression 
H-positive risk:  674 667 108 1112 386 84 1150 405 147 63 145 59 
H-negative risk:  667 674 1150 1112 405 386 84 108 145 147 59 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
142 
disease_progression 
H-positive risk:  663 666 106 1122 388 82 1150 406 146 66 147 58 
H-negative risk:  666 663 1150 1122 406 388 82 106 147 146 58 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
143 
disease_progression 
H-positive risk:  668 670 105 1127 381 83 1145 403 146 68 148 56 
H-negative risk:  670 668 1145 1127 403 381 83 105 148 146 56 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
144 
disease_progression 
H-positive risk:  672 675 105 1117 380 85 1136 405 149 69 147 60 
H-negative risk:  675 672 1136 1117 405 380 85 105 147 149 60 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
145 
disease_progression 
H-positive risk:  675 670 102 1120 374 86 1139 411 147 67 150 59 
H-negative risk:  670 675 1139 1120 411 374 86 102 150 147 59 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
146 
disease_progression 
H-positive risk:  672 679 102 1109 387 85 1124 412 150 68 152 60 
H-negative risk:  679 672 1124 1109 412 387 85 102 152 150 60 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
147 
disease_progression 
H-positive risk:  678 678 102 1104 390 84 1120 414 148 71 151 60 
H-negative risk:  678 678 1120 1104 414 390 84 102 151 148 60 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
148 
disease_progression 
H-positive risk:  670 673 108 1112 391 83 1122 411 148 72 150 60 
H-negative risk:  673 670 1122 1112 411 391 83 108 150 148 60 72 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
149 
disease_progression 
H-positive risk:  676 688 108 1107 390 83 1108 414 146 71 152 57 
H-negative risk:  688 676 1108 1107 414 390 83 108 152 146 57 71 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
150 
disease_progression 
H-positive risk:  677 690 106 1107 397 82 1107 407 144 74 152 57 
H-negative risk:  690 677 1107 1107 407 397 82 106 152 144 57 74 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
151 
disease_progression 
H-positive risk:  679 688 104 1104 397 83 1103 410 146 72 153 61 
H-negative risk:  688 679 1103 1104 410 397 83 104 153 146 61 72 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
152 
disease_progression 
H-positive risk:  680 689 105 1107 396 86 1105 401 143 73 151 64 
H-negative risk:  689 680 1105 1107 401 396 86 105 151 143 64 73 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
153 
disease_progression 
H-positive risk:  671 691 106 1106 397 87 1115 395 140 73 152 67 
H-negative risk:  691 671 1115 1106 395 397 87 106 152 140 67 73 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
154 
disease_progression 
H-positive risk:  669 694 102 1106 397 85 1121 386 142 74 156 68 
H-negative risk:  694 669 1121 1106 386 397 85 102 156 142 68 74 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
155 
disease_progression 
H-positive risk:  671 687 104 1113 396 84 1124 380 141 77 157 66 
H-negative risk:  687 671 1124 1113 380 396 84 104 157 141 66 77 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
156 
disease_progression 
H-positive risk:  674 686 104 1105 402 84 1131 377 142 76 154 65 
H-negative risk:  686 674 1131 1105 377 402 84 104 154 142 65 76 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  687 678 106 1114 399 83 1118 378 140 76 156 65 
H-negative risk:  678 687 1118 1114 378 399 83 106 156 140 65 76 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
158 
disease_progression 
H-positive risk:  688 673 106 1102 409 82 1123 382 138 75 157 65 
H-negative risk:  673 688 1123 1102 382 409 82 106 157 138 65 75 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
159 
disease_progression 
H-positive risk:  689 677 107 1088 403 80 1122 396 142 75 156 65 
H-negative risk:  677 689 1122 1088 396 403 80 107 156 142 65 75 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
160 
disease_progression 
H-positive risk:  701 682 105 1082 406 80 1113 397 142 74 153 65 
H-negative risk:  682 701 1113 1082 397 406 80 105 153 142 65 74 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
161 
disease_progression 
H-positive risk:  699 686 102 1081 403 78 1123 396 142 72 155 63 
H-negative risk:  686 699 1123 1081 396 403 78 102 155 142 63 72 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
162 
disease_progression 
H-positive risk:  697 683 103 1081 410 79 1126 392 144 71 153 61 
H-negative risk:  683 697 1126 1081 392 410 79 103 153 144 61 71 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
163 
disease_progression 
H-positive risk:  701 688 102 1083 405 81 1129 389 145 64 156 57 
H-negative risk:  688 701 1129 1083 389 405 81 102 156 145 57 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
164 
disease_progression 
H-positive risk:  697 691 102 1084 401 80 1129 388 148 62 161 57 
H-negative risk:  691 697 1129 1084 388 401 80 102 161 148 57 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
165 
disease_progression 
H-positive risk:  699 697 99 1080 408 79 1132 376 148 62 162 58 
H-negative risk:  697 699 1132 1080 376 408 79 99 162 148 58 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
166 
disease_progression 
H-positive risk:  694 697 99 1089 412 81 1126 374 147 63 157 61 
H-negative risk:  697 694 1126 1089 374 412 81 99 157 147 61 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
167 
disease_progression 
H-positive risk:  693 707 98 1092 409 82 1125 374 141 60 160 59 
H-negative risk:  707 693 1125 1092 374 409 82 98 160 141 59 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
168 
disease_progression 
H-positive risk:  693 709 95 1087 407 83 1126 380 141 56 162 61 
H-negative risk:  709 693 1126 1087 380 407 83 95 162 141 61 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
169 
disease_progression 
H-positive risk:  696 710 95 1088 404 86 1117 381 143 59 162 59 
H-negative risk:  710 696 1117 1088 381 404 86 95 162 143 59 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
170 
disease_progression 
H-positive risk:  698 711 98 1075 411 84 1111 386 144 59 160 63 
H-negative risk:  711 698 1111 1075 386 411 84 98 160 144 63 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
171 
disease_progression 
H-positive risk:  695 705 103 1082 413 84 1115 380 142 60 156 65 
H-negative risk:  705 695 1115 1082 380 413 84 103 156 142 65 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
172 
disease_progression 
H-positive risk:  697 700 100 1085 417 86 1109 382 143 61 158 62 
H-negative risk:  700 697 1109 1085 382 417 86 100 158 143 62 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
173 
disease_progression 
H-positive risk:  695 702 99 1092 414 88 1105 381 143 59 161 61 
H-negative risk:  702 695 1105 1092 381 414 88 99 161 143 61 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
174 
disease_progression 
H-positive risk:  692 698 100 1093 416 89 1100 387 143 59 161 62 
H-negative risk:  698 692 1100 1093 387 416 89 100 161 143 62 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
175 
disease_progression 
H-positive risk:  698 692 102 1089 414 92 1095 391 145 57 163 62 
H-negative risk:  692 698 1095 1089 391 414 92 102 163 145 62 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
176 
disease_progression 
H-positive risk:  696 689 102 1084 420 91 1096 391 147 57 164 63 
H-negative risk:  689 696 1096 1084 391 420 91 102 164 147 63 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
177 
disease_progression 
H-positive risk:  696 688 104 1081 423 93 1096 388 147 57 162 65 
H-negative risk:  688 696 1096 1081 388 423 93 104 162 147 65 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
178 
disease_progression 
H-positive risk:  698 681 100 1082 429 92 1099 387 149 56 165 62 
H-negative risk:  681 698 1099 1082 387 429 92 100 165 149 62 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
179 
disease_progression 
H-positive risk:  704 667 97 1099 425 91 1103 385 150 54 164 61 
H-negative risk:  667 704 1103 1099 385 425 91 97 164 150 61 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
180 
disease_progression 
H-positive risk:  697 677 97 1100 423 93 1102 376 148 60 167 60 
H-negative risk:  677 697 1102 1100 376 423 93 97 167 148 60 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
181 
disease_progression 
H-positive risk:  699 674 97 1107 422 91 1092 379 153 59 170 57 
H-negative risk:  674 699 1092 1107 379 422 91 97 170 153 57 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
182 
disease_progression 
H-positive risk:  684 675 94 1096 432 95 1097 381 152 60 171 63 
H-negative risk:  675 684 1097 1096 381 432 95 94 171 152 63 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  686 680 93 1095 427 96 1087 394 150 61 168 63 
H-negative risk:  680 686 1087 1095 394 427 96 93 168 150 63 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
184 
disease_progression 
H-positive risk:  689 676 90 1092 433 91 1092 393 153 61 169 61 
H-negative risk:  676 689 1092 1092 393 433 91 90 169 153 61 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
185 
disease_progression 
H-positive risk:  685 674 91 1096 419 91 1095 409 154 61 169 56 
H-negative risk:  674 685 1095 1096 409 419 91 91 169 154 56 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
186 
disease_progression 
H-positive risk:  684 677 92 1098 416 91 1098 404 158 60 168 54 
H-negative risk:  677 684 1098 1098 404 416 91 92 168 158 54 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
187 
disease_progression 
H-positive risk:  685 678 91 1102 415 93 1093 404 157 57 166 59 
H-negative risk:  678 685 1093 1102 404 415 93 91 166 157 59 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
188 
disease_progression 
H-positive risk:  684 677 93 1112 418 92 1084 405 151 59 165 60 
H-negative risk:  677 684 1084 1112 405 418 92 93 165 151 60 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
189 
disease_progression 
H-positive risk:  690 688 96 1105 407 93 1082 403 148 63 162 63 
H-negative risk:  688 690 1082 1105 403 407 93 96 162 148 63 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
190 
disease_progression 
H-positive risk:  693 689 94 1105 412 93 1075 405 150 63 160 61 
H-negative risk:  689 693 1075 1105 405 412 93 94 160 150 61 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
191 
disease_progression 
H-positive risk:  694 692 95 1103 410 96 1069 407 151 62 161 60 
H-negative risk:  692 694 1069 1103 407 410 96 95 161 151 60 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
192 
disease_progression 
H-positive risk:  699 687 94 1107 414 95 1059 412 151 62 156 64 
H-negative risk:  687 699 1059 1107 412 414 95 94 156 151 64 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
193 
disease_progression 
H-positive risk:  690 689 95 1109 417 96 1063 411 150 59 159 62 
H-negative risk:  689 690 1063 1109 411 417 96 95 159 150 62 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
100 new agents 
194 
disease_progression 
H-positive risk:  694 703 93 1089 417 97 1053 412 154 60 161 67 
H-negative risk:  703 694 1053 1089 412 417 97 93 161 154 67 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
195 
disease_progression 
H-positive risk:  702 704 93 1082 417 97 1044 414 155 62 163 67 
H-negative risk:  704 702 1044 1082 414 417 97 93 163 155 67 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
196 
disease_progression 
H-positive risk:  706 694 94 1085 427 97 1045 409 154 65 160 64 
H-negative risk:  694 706 1045 1085 409 427 97 94 160 154 64 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
197 
disease_progression 
H-positive risk:  707 697 94 1079 430 94 1050 412 153 60 159 65 
H-negative risk:  697 707 1050 1079 412 430 94 94 159 153 65 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
198 
disease_progression 
H-positive risk:  709 691 93 1083 437 95 1052 408 151 57 158 66 
H-negative risk:  691 709 1052 1083 408 437 95 93 158 151 66 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
199 
disease_progression 
H-positive risk:  706 694 89 1085 434 95 1049 412 154 58 159 65 
H-negative risk:  694 706 1049 1085 412 434 95 89 159 154 65 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
200 
disease_progression 
H-positive risk:  710 692 89 1077 435 97 1053 416 155 55 156 65 
H-negative risk:  692 710 1053 1077 416 435 97 89 156 155 65 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
201 
disease_progression 
H-positive risk:  714 689 89 1081 429 97 1049 425 154 54 153 66 
H-negative risk:  689 714 1049 1081 425 429 97 89 153 154 66 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
202 
disease_progression 
H-positive risk:  710 693 87 1075 428 100 1058 422 155 55 152 65 
H-negative risk:  693 710 1058 1075 422 428 100 87 152 155 65 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
203 
disease_progression 
H-positive risk:  717 684 86 1070 430 99 1062 425 154 56 149 68 
H-negative risk:  684 717 1062 1070 425 430 99 86 149 154 68 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
204 
disease_progression 
H-positive risk:  719 683 87 1080 428 99 1060 418 153 55 150 68 
H-negative risk:  683 719 1060 1080 418 428 99 87 150 153 68 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
205 
disease_progression 
H-positive risk:  723 686 86 1085 424 104 1052 414 154 52 154 66 
H-negative risk:  686 723 1052 1085 414 424 104 86 154 154 66 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
206 
disease_progression 
H-positive risk:  717 680 84 1083 436 100 1055 422 155 51 152 65 
H-negative risk:  680 717 1055 1083 422 436 100 84 152 155 65 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
207 
disease_progression 
H-positive risk:  706 684 84 1085 429 101 1059 425 156 51 155 65 
H-negative risk:  684 706 1059 1085 425 429 101 84 155 156 65 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
208 
disease_progression 
H-positive risk:  708 677 83 1088 433 97 1062 425 159 48 157 63 
H-negative risk:  677 708 1062 1088 425 433 97 83 157 159 63 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
209 
disease_progression 
H-positive risk:  706 680 82 1083 436 97 1063 421 162 49 158 63 
H-negative risk:  680 706 1063 1083 421 436 97 82 158 162 63 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
210 
disease_progression 
H-positive risk:  711 677 83 1084 432 102 1065 419 163 48 154 62 
H-negative risk:  677 711 1065 1084 419 432 102 83 154 163 62 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
97 new agents 
211 
disease_progression 
H-positive risk:  714 671 84 1083 427 101 1069 419 165 49 157 61 
H-negative risk:  671 714 1069 1083 419 427 101 84 157 165 61 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
212 
disease_progression 
H-positive risk:  715 671 83 1094 418 100 1075 412 163 49 159 61 
H-negative risk:  671 715 1075 1094 412 418 100 83 159 163 61 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
213 
disease_progression 
H-positive risk:  718 665 84 1099 411 101 1080 412 164 48 157 61 
H-negative risk:  665 718 1080 1099 412 411 101 84 157 164 61 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  715 670 83 1095 409 99 1081 418 166 48 156 60 
H-negative risk:  670 715 1081 1095 418 409 99 83 156 166 60 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
215 
disease_progression 
H-positive risk:  717 669 84 1097 415 100 1074 418 168 45 156 57 
H-negative risk:  669 717 1074 1097 418 415 100 84 156 168 57 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
216 
disease_progression 
H-positive risk:  714 667 88 1101 401 99 1081 424 169 46 154 56 
H-negative risk:  667 714 1081 1101 424 401 99 88 154 169 56 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
217 
disease_progression 
H-positive risk:  720 677 84 1091 410 98 1060 433 172 47 154 54 
H-negative risk:  677 720 1060 1091 433 410 98 84 154 172 54 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
218 
disease_progression 
H-positive risk:  723 675 80 1099 409 97 1052 435 173 46 156 55 
H-negative risk:  675 723 1052 1099 435 409 97 80 156 173 55 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
219 
disease_progression 
H-positive risk:  720 686 80 1103 401 97 1049 439 171 44 152 58 
H-negative risk:  686 720 1049 1103 439 401 97 80 152 171 58 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
220 
disease_progression 
H-positive risk:  723 690 81 1107 392 96 1052 438 170 44 150 57 
H-negative risk:  690 723 1052 1107 438 392 96 81 150 170 57 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
221 
disease_progression 
H-positive risk:  725 692 79 1099 395 95 1052 444 171 42 151 55 
H-negative risk:  692 725 1052 1099 444 395 95 79 151 171 55 42 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
222 
disease_progression 
H-positive risk:  720 690 76 1098 393 95 1056 443 174 45 155 55 
H-negative risk:  690 720 1056 1098 443 393 95 76 155 174 55 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
223 
disease_progression 
H-positive risk:  719 692 77 1091 402 94 1062 436 175 44 156 52 
H-negative risk:  692 719 1062 1091 436 402 94 77 156 175 52 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
224 
disease_progression 
H-positive risk:  717 687 74 1088 405 93 1068 442 176 45 157 48 
H-negative risk:  687 717 1068 1088 442 405 93 74 157 176 48 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
225 
disease_progression 
H-positive risk:  716 692 73 1084 407 93 1074 437 177 46 155 46 
H-negative risk:  692 716 1074 1084 437 407 93 73 155 177 46 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
226 
disease_progression 
H-positive risk:  716 695 74 1082 408 91 1074 437 177 45 151 50 
H-negative risk:  695 716 1074 1082 437 408 91 74 151 177 50 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 97 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
227 
disease_progression 
H-positive risk:  706 691 73 1076 413 91 1083 440 178 48 149 52 
H-negative risk:  691 706 1083 1076 440 413 91 73 149 178 52 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 97 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
228 
disease_progression 
H-positive risk:  698 695 69 1075 417 91 1091 434 177 47 151 55 
H-negative risk:  695 698 1091 1075 434 417 91 69 151 177 55 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
229 
disease_progression 
H-positive risk:  695 700 68 1057 434 91 1091 438 172 49 150 55 
H-negative risk:  700 695 1091 1057 438 434 91 68 150 172 55 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 97 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
230 
disease_progression 
H-positive risk:  693 701 70 1066 431 91 1090 432 170 49 154 53 
H-negative risk:  701 693 1090 1066 432 431 91 70 154 170 53 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 101 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
231 
disease_progression 
H-positive risk:  693 696 70 1068 436 88 1093 430 168 51 155 52 
H-negative risk:  696 693 1093 1068 430 436 88 70 155 168 52 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 102 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  697 695 69 1074 433 90 1091 428 164 52 156 51 
H-negative risk:  695 697 1091 1074 428 433 90 69 156 164 51 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 106 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
233 
disease_progression 
H-positive risk:  703 691 72 1069 433 91 1086 433 165 51 156 50 
H-negative risk:  691 703 1086 1069 433 433 91 72 156 165 50 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 105 13 

clinical_engagement 
diagnosis 
demography 
89 new agents 
234 
disease_progression 
H-positive risk:  710 697 71 1072 435 92 1084 425 164 45 157 48 
H-negative risk:  697 710 1084 1072 425 435 92 71 157 164 48 45 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 108 13 

clinical_engagement 
diagnosis 
demography 
81 new agents 
235 
disease_progression 
H-positive risk:  705 704 70 1066 437 91 1102 415 162 46 155 47 
H-negative risk:  704 705 1102 1066 415 437 91 70 155 162 47 46 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 112 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
236 
disease_progression 
H-positive risk:  706 689 68 1065 434 91 1112 421 159 50 157 48 
H-negative risk:  689 706 1112 1065 421 434 91 68 157 159 48 50 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 114 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
237 
disease_progression 
H-positive risk:  707 687 67 1078 424 90 1117 412 158 53 158 49 
H-negative risk:  687 707 1117 1078 412 424 90 67 158 158 49 53 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 115 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
238 
disease_progression 
H-positive risk:  700 688 70 1078 433 90 1111 409 159 54 160 48 
H-negative risk:  688 700 1111 1078 409 433 90 70 160 159 48 54 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 113 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
239 
disease_progression 
H-positive risk:  698 692 71 1081 428 89 1114 405 161 56 159 46 
H-negative risk:  692 698 1114 1081 405 428 89 71 159 161 46 56 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 113 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
240 
disease_progression 
H-positive risk:  704 697 71 1065 431 86 1111 416 160 57 155 47 
H-negative risk:  697 704 1111 1065 416 431 86 71 155 160 47 57 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 112 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
241 
disease_progression 
H-positive risk:  694 695 72 1064 435 85 1106 425 166 53 155 50 
H-negative risk:  695 694 1106 1064 425 435 85 72 155 166 50 53 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 109 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
242 
disease_progression 
H-positive risk:  697 683 73 1075 425 84 1114 425 167 56 149 52 
H-negative risk:  683 697 1114 1075 425 425 84 73 149 167 52 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 105 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
243 
disease_progression 
H-positive risk:  695 674 73 1073 423 85 1108 437 171 56 151 54 
H-negative risk:  674 695 1108 1073 437 423 85 73 151 171 54 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 102 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
244 
disease_progression 
H-positive risk:  692 672 70 1077 423 86 1118 431 171 57 149 54 
H-negative risk:  672 692 1118 1077 431 423 86 70 149 171 54 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
245 
disease_progression 
H-positive risk:  691 674 73 1073 427 86 1117 428 172 56 147 56 
H-negative risk:  674 691 1117 1073 428 427 86 73 147 172 56 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
246 
disease_progression 
H-positive risk:  687 668 76 1077 424 86 1112 437 175 57 142 59 
H-negative risk:  668 687 1112 1077 437 424 86 76 142 175 59 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
247 
disease_progression 
H-positive risk:  687 671 76 1079 419 85 1120 433 174 55 141 60 
H-negative risk:  671 687 1120 1079 433 419 85 76 141 174 60 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
248 
disease_progression 
H-positive risk:  688 674 81 1079 413 84 1120 431 172 54 142 62 
H-negative risk:  674 688 1120 1079 431 413 84 81 142 172 62 54 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 100 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
249 
disease_progression 
H-positive risk:  694 671 79 1082 410 84 1125 426 173 53 142 61 
H-negative risk:  671 694 1125 1082 426 410 84 79 142 173 61 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
250 
disease_progression 
H-positive risk:  697 665 80 1084 410 83 1127 423 169 55 142 65 
H-negative risk:  665 697 1127 1084 423 410 83 80 142 169 65 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
251 
disease_progression 
H-positive risk:  697 671 79 1078 409 84 1120 429 168 56 144 65 
H-negative risk:  671 697 1120 1078 429 409 84 79 144 168 65 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
252 
disease_progression 
H-positive risk:  687 677 77 1077 418 83 1134 425 161 57 142 62 
H-negative risk:  677 687 1134 1077 425 418 83 77 142 161 62 57 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
253 
disease_progression 
H-positive risk:  689 671 78 1078 422 83 1139 419 163 54 140 64 
H-negative risk:  671 689 1139 1078 419 422 83 78 140 163 64 54 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 99 26 

clinical_engagement 
diagnosis 
demography 
94 new agents 
254 
disease_progression 
H-positive risk:  692 683 78 1067 418 86 1142 411 160 55 144 64 
H-negative risk:  683 692 1142 1067 411 418 86 78 144 160 64 55 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
255 
disease_progression 
H-positive risk:  689 680 79 1065 423 84 1145 413 160 58 143 61 
H-negative risk:  680 689 1145 1065 413 423 84 79 143 160 61 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 99 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
256 
disease_progression 
H-positive risk:  680 684 82 1058 420 81 1151 413 164 57 147 63 
H-negative risk:  684 680 1151 1058 413 420 81 82 147 164 63 57 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
97 new agents 
257 
disease_progression 
H-positive risk:  674 687 81 1067 416 81 1155 408 165 56 147 63 
H-negative risk:  687 674 1155 1067 408 416 81 81 147 165 63 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 97 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
258 
disease_progression 
H-positive risk:  679 688 83 1064 414 83 1155 405 167 55 149 58 
H-negative risk:  688 679 1155 1064 405 414 83 83 149 167 58 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 96 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
259 
disease_progression 
H-positive risk:  676 692 83 1076 407 86 1152 398 163 58 152 57 
H-negative risk:  692 676 1152 1076 398 407 86 83 152 163 57 58 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
260 
disease_progression 
H-positive risk:  670 701 81 1068 409 84 1162 396 162 57 153 57 
H-negative risk:  701 670 1162 1068 396 409 84 81 153 162 57 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
261 
disease_progression 
H-positive risk:  667 708 80 1065 411 85 1159 401 160 55 151 58 
H-negative risk:  708 667 1159 1065 401 411 85 80 151 160 58 55 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 103 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
262 
disease_progression 
H-positive risk:  675 707 81 1060 415 86 1148 408 160 55 146 59 
H-negative risk:  707 675 1148 1060 408 415 86 81 146 160 59 55 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 104 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
263 
disease_progression 
H-positive risk:  677 700 81 1071 415 88 1141 412 159 55 145 56 
H-negative risk:  700 677 1141 1071 412 415 88 81 145 159 56 55 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
264 
disease_progression 
H-positive risk:  673 692 81 1085 420 88 1130 420 157 53 147 54 
H-negative risk:  692 673 1130 1085 420 420 88 81 147 157 54 53 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 98 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
265 
disease_progression 
H-positive risk:  668 693 81 1097 411 88 1130 423 156 54 144 55 
H-negative risk:  693 668 1130 1097 423 411 88 81 144 156 55 54 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 99 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
266 
disease_progression 
H-positive risk:  670 688 81 1091 414 88 1130 422 161 59 141 55 
H-negative risk:  688 670 1130 1091 422 414 88 81 141 161 55 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 97 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
267 
disease_progression 
H-positive risk:  667 688 82 1091 418 89 1138 415 158 56 141 57 
H-negative risk:  688 667 1138 1091 415 418 89 82 141 158 57 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 96 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
268 
disease_progression 
H-positive risk:  661 695 82 1093 416 92 1134 414 157 55 144 57 
H-negative risk:  695 661 1134 1093 414 416 92 82 144 157 57 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
269 
disease_progression 
H-positive risk:  660 699 85 1094 411 93 1133 413 153 61 142 56 
H-negative risk:  699 660 1133 1094 413 411 93 85 142 153 56 61 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 98 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
270 
disease_progression 
H-positive risk:  664 699 86 1095 419 92 1131 403 153 60 144 54 
H-negative risk:  699 664 1131 1095 403 419 92 86 144 153 54 60 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 102 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
271 
disease_progression 
H-positive risk:  668 699 84 1095 414 92 1135 404 153 60 137 59 
H-negative risk:  699 668 1135 1095 404 414 92 84 137 153 59 60 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 103 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
272 
disease_progression 
H-positive risk:  670 695 84 1083 423 92 1136 407 152 59 142 57 
H-negative risk:  695 670 1136 1083 407 423 92 84 142 152 57 59 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
273 
disease_progression 
H-positive risk:  666 692 82 1091 423 92 1141 407 152 58 142 54 
H-negative risk:  692 666 1141 1091 407 423 92 82 142 152 54 58 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 106 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
274 
disease_progression 
H-positive risk:  665 691 81 1095 417 93 1145 407 149 58 145 54 
H-negative risk:  691 665 1145 1095 407 417 93 81 145 149 54 58 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
102 new agents 
275 
disease_progression 
H-positive risk:  671 694 83 1095 408 93 1140 409 151 58 146 52 
H-negative risk:  694 671 1140 1095 409 408 93 83 146 151 52 58 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 103 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
276 
disease_progression 
H-positive risk:  672 693 82 1097 407 96 1138 408 149 60 147 51 
H-negative risk:  693 672 1138 1097 408 407 96 82 147 149 51 60 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 101 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
277 
disease_progression 
H-positive risk:  678 701 84 1091 404 97 1140 393 153 61 146 52 
H-negative risk:  701 678 1140 1091 393 404 97 84 146 153 52 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
278 
disease_progression 
H-positive risk:  676 695 83 1096 408 98 1134 399 150 65 146 50 
H-negative risk:  695 676 1134 1096 399 408 98 83 146 150 50 65 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 101 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
279 
disease_progression 
H-positive risk:  683 692 80 1096 400 97 1133 406 151 65 146 51 
H-negative risk:  692 683 1133 1096 406 400 97 80 146 151 51 65 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
280 
disease_progression 
H-positive risk:  684 690 81 1092 401 99 1133 410 154 64 144 48 
H-negative risk:  690 684 1133 1092 410 401 99 81 144 154 48 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
281 
disease_progression 
H-positive risk:  687 687 80 1082 407 99 1131 413 155 65 145 49 
H-negative risk:  687 687 1131 1082 413 407 99 80 145 155 49 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
282 
disease_progression 
H-positive risk:  689 687 79 1087 405 99 1124 415 157 64 145 49 
H-negative risk:  687 689 1124 1087 415 405 99 79 145 157 49 64 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
283 
disease_progression 
H-positive risk:  703 682 74 1079 414 96 1120 412 159 68 145 48 
H-negative risk:  682 703 1120 1079 412 414 96 74 145 159 48 68 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
284 
disease_progression 
H-positive risk:  704 678 77 1079 419 96 1119 414 156 69 141 48 
H-negative risk:  678 704 1119 1079 414 419 96 77 141 156 48 69 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
285 
disease_progression 
H-positive risk:  702 677 76 1068 423 97 1128 412 160 67 142 48 
H-negative risk:  677 702 1128 1068 412 423 97 76 142 160 48 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
286 
disease_progression 
H-positive risk:  699 678 77 1062 420 98 1117 423 164 71 142 49 
H-negative risk:  678 699 1117 1062 423 420 98 77 142 164 49 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
287 
disease_progression 
H-positive risk:  701 677 77 1075 411 98 1116 417 164 73 141 50 
H-negative risk:  677 701 1116 1075 417 411 98 77 141 164 50 73 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
288 
disease_progression 
H-positive risk:  709 671 79 1087 405 97 1115 414 162 72 141 48 
H-negative risk:  671 709 1115 1087 414 405 97 79 141 162 48 72 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
94 new agents 
289 
disease_progression 
H-positive risk:  724 657 79 1091 404 96 1105 417 163 73 139 52 
H-negative risk:  657 724 1105 1091 417 404 96 79 139 163 52 73 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
290 
disease_progression 
H-positive risk:  722 654 80 1107 399 97 1109 409 161 72 136 54 
H-negative risk:  654 722 1109 1107 409 399 97 80 136 161 54 72 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
103 new agents 
291 
disease_progression 
H-positive risk:  723 652 81 1110 396 98 1109 408 158 73 137 55 
H-negative risk:  652 723 1109 1110 408 396 98 81 137 158 55 73 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
292 
disease_progression 
H-positive risk:  719 659 82 1116 390 99 1105 404 162 72 136 56 
H-negative risk:  659 719 1105 1116 404 390 99 82 136 162 56 72 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
293 
disease_progression 
H-positive risk:  725 661 82 1110 388 98 1093 418 160 74 132 59 
H-negative risk:  661 725 1093 1110 418 388 98 82 132 160 59 74 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
294 
disease_progression 
H-positive risk:  720 663 81 1109 391 95 1092 414 169 74 131 61 
H-negative risk:  663 720 1092 1109 414 391 95 81 131 169 61 74 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
295 
disease_progression 
H-positive risk:  720 662 81 1108 389 95 1095 417 168 74 131 60 
H-negative risk:  662 720 1095 1108 417 389 95 81 131 168 60 74 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
296 
disease_progression 
H-positive risk:  719 658 82 1107 391 97 1094 418 164 77 128 65 
H-negative risk:  658 719 1094 1107 418 391 97 82 128 164 65 77 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
297 
disease_progression 
H-positive risk:  710 662 82 1106 396 94 1091 424 167 76 128 64 
H-negative risk:  662 710 1091 1106 424 396 94 82 128 167 64 76 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
298 
disease_progression 
H-positive risk:  712 673 83 1100 393 94 1087 426 167 77 124 64 
H-negative risk:  673 712 1087 1100 426 393 94 83 124 167 64 77 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
299 
disease_progression 
H-positive risk:  707 673 85 1108 392 93 1081 428 166 75 125 67 
H-negative risk:  673 707 1081 1108 428 392 93 85 125 166 67 75 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
300 
disease_progression 
H-positive risk:  703 675 85 1105 382 88 1085 441 170 74 125 67 
H-negative risk:  675 703 1085 1105 441 382 88 85 125 170 67 74 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
301 
disease_progression 
H-positive risk:  703 674 88 1093 388 91 1084 446 168 76 122 67 
H-negative risk:  674 703 1084 1093 446 388 91 88 122 168 67 76 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
302 
disease_progression 
H-positive risk:  704 669 89 1092 387 90 1091 441 167 78 124 68 
H-negative risk:  669 704 1091 1092 441 387 90 89 124 167 68 78 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
303 
disease_progression 
H-positive risk:  702 671 89 1090 386 91 1094 447 166 73 121 70 
H-negative risk:  671 702 1094 1090 447 386 91 89 121 166 70 73 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
304 
disease_progression 
H-positive risk:  705 669 91 1089 393 93 1092 439 165 73 120 71 
H-negative risk:  669 705 1092 1089 439 393 93 91 120 165 71 73 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
305 
disease_progression 
H-positive risk:  709 663 87 1089 393 96 1095 434 168 74 120 72 
H-negative risk:  663 709 1095 1089 434 393 96 87 120 168 72 74 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
306 
disease_progression 
H-positive risk:  709 671 86 1080 395 92 1091 438 173 74 119 72 
H-negative risk:  671 709 1091 1080 438 395 92 86 119 173 72 74 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
307 
disease_progression 
H-positive risk:  713 671 86 1092 389 90 1079 439 173 75 121 72 
H-negative risk:  671 713 1079 1092 439 389 90 86 121 173 72 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
308 
disease_progression 
H-positive risk:  709 680 84 1088 389 90 1084 441 170 74 120 71 
H-negative risk:  680 709 1084 1088 441 389 90 84 120 170 71 74 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
309 
disease_progression 
H-positive risk:  712 681 83 1083 388 90 1085 441 172 73 122 70 
H-negative risk:  681 712 1085 1083 441 388 90 83 122 172 70 73 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
54 new agents 
310 
disease_progression 
H-positive risk:  717 673 83 1087 384 90 1084 447 170 75 122 68 
H-negative risk:  673 717 1084 1087 447 384 90 83 122 170 68 75 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
311 
disease_progression 
H-positive risk:  712 672 85 1089 384 90 1087 452 167 75 120 67 
H-negative risk:  672 712 1087 1089 452 384 90 85 120 167 67 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
312 
disease_progression 
H-positive risk:  708 677 88 1085 387 90 1088 452 165 71 121 68 
H-negative risk:  677 708 1088 1085 452 387 90 88 121 165 68 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
313 
disease_progression 
H-positive risk:  710 669 95 1090 384 88 1086 450 167 72 124 65 
H-negative risk:  669 710 1086 1090 450 384 88 95 124 167 65 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
314 
disease_progression 
H-positive risk:  703 667 93 1091 394 83 1089 450 169 72 122 67 
H-negative risk:  667 703 1089 1091 450 394 83 93 122 169 67 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
315 
disease_progression 
H-positive risk:  706 668 89 1088 388 82 1092 452 166 73 123 73 
H-negative risk:  668 706 1092 1088 452 388 82 89 123 166 73 73 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
316 
disease_progression 
H-positive risk:  706 670 91 1088 388 83 1086 454 165 74 123 72 
H-negative risk:  670 706 1086 1088 454 388 83 91 123 165 72 74 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
317 
disease_progression 
H-positive risk:  714 671 90 1083 389 83 1085 452 162 77 124 70 
H-negative risk:  671 714 1085 1083 452 389 83 90 124 162 70 77 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
318 
disease_progression 
H-positive risk:  712 674 92 1081 388 84 1083 451 163 79 124 69 
H-negative risk:  674 712 1083 1081 451 388 84 92 124 163 69 79 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
319 
disease_progression 
H-positive risk:  716 674 90 1079 388 87 1079 455 161 79 128 64 
H-negative risk:  674 716 1079 1079 455 388 87 90 128 161 64 79 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
320 
disease_progression 
H-positive risk:  727 675 85 1081 379 87 1084 450 160 77 131 64 
H-negative risk:  675 727 1084 1081 450 379 87 85 131 160 64 77 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
321 
disease_progression 
H-positive risk:  724 683 84 1078 374 85 1096 440 159 79 132 66 
H-negative risk:  683 724 1096 1078 440 374 85 84 132 159 66 79 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
322 
disease_progression 
H-positive risk:  722 684 82 1084 383 86 1095 428 159 80 134 63 
H-negative risk:  684 722 1095 1084 428 383 86 82 134 159 63 80 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
323 
disease_progression 
H-positive risk:  716 686 82 1077 392 90 1099 423 158 81 135 61 
H-negative risk:  686 716 1099 1077 423 392 90 82 135 158 61 81 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
324 
disease_progression 
H-positive risk:  710 685 83 1073 398 94 1106 420 155 81 135 60 
H-negative risk:  685 710 1106 1073 420 398 94 83 135 155 60 81 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
325 
disease_progression 
H-positive risk:  706 683 81 1071 398 94 1116 415 156 79 137 64 
H-negative risk:  683 706 1116 1071 415 398 94 81 137 156 64 79 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
326 
disease_progression 
H-positive risk:  698 688 80 1070 399 93 1119 414 159 79 138 63 
H-negative risk:  688 698 1119 1070 414 399 93 80 138 159 63 79 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
327 
disease_progression 
H-positive risk:  698 683 77 1077 393 93 1120 421 158 78 141 61 
H-negative risk:  683 698 1120 1077 421 393 93 77 141 158 61 78 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
328 
disease_progression 
H-positive risk:  694 687 74 1083 391 92 1120 424 158 75 144 58 
H-negative risk:  687 694 1120 1083 424 391 92 74 144 158 58 75 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
329 
disease_progression 
H-positive risk:  695 695 74 1080 404 94 1106 425 153 74 140 60 
H-negative risk:  695 695 1106 1080 425 404 94 74 140 153 60 74 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
330 
disease_progression 
H-positive risk:  698 697 74 1075 411 95 1107 415 154 71 139 64 
H-negative risk:  697 698 1107 1075 415 411 95 74 139 154 64 71 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
331 
disease_progression 
H-positive risk:  696 698 75 1071 420 95 1097 423 157 70 139 59 
H-negative risk:  698 696 1097 1071 423 420 95 75 139 157 59 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
332 
disease_progression 
H-positive risk:  698 705 75 1060 420 90 1093 428 158 75 140 58 
H-negative risk:  705 698 1093 1060 428 420 90 75 140 158 58 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
333 
disease_progression 
H-positive risk:  694 694 73 1066 426 89 1096 430 157 76 140 59 
H-negative risk:  694 694 1096 1066 430 426 89 73 140 157 59 76 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
334 
disease_progression 
H-positive risk:  697 693 76 1058 427 87 1100 431 158 73 143 57 
H-negative risk:  693 697 1100 1058 431 427 87 76 143 158 57 73 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
335 
disease_progression 
H-positive risk:  699 692 77 1059 429 84 1100 428 159 75 145 53 
H-negative risk:  692 699 1100 1059 428 429 84 77 145 159 53 75 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
336 
disease_progression 
H-positive risk:  692 692 76 1063 426 87 1095 439 160 76 144 50 
H-negative risk:  692 692 1095 1063 439 426 87 76 144 160 50 76 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
337 
disease_progression 
H-positive risk:  687 702 77 1047 432 86 1108 429 162 75 142 53 
H-negative risk:  702 687 1108 1047 429 432 86 77 142 162 53 75 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
338 
disease_progression 
H-positive risk:  695 700 78 1045 431 88 1105 435 161 71 138 53 
H-negative risk:  700 695 1105 1045 435 431 88 78 138 161 53 71 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
339 
disease_progression 
H-positive risk:  701 699 79 1048 431 86 1110 429 158 68 135 56 
H-negative risk:  699 701 1110 1048 429 431 86 79 135 158 56 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
340 
disease_progression 
H-positive risk:  703 696 81 1065 422 88 1103 426 162 66 133 55 
H-negative risk:  696 703 1103 1065 426 422 88 81 133 162 55 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
341 
disease_progression 
H-positive risk:  701 701 78 1067 424 87 1097 430 165 63 134 53 
H-negative risk:  701 701 1097 1067 430 424 87 78 134 165 53 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
342 
disease_progression 
H-positive risk:  698 701 78 1072 424 87 1107 420 164 61 135 53 
H-negative risk:  701 698 1107 1072 420 424 87 78 135 164 53 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
343 
disease_progression 
H-positive risk:  704 705 77 1074 416 90 1104 419 166 60 133 52 
H-negative risk:  705 704 1104 1074 419 416 90 77 133 166 52 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
344 
disease_progression 
H-positive risk:  702 703 75 1085 407 89 1108 421 165 61 131 53 
H-negative risk:  703 702 1108 1085 421 407 89 75 131 165 53 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
345 
disease_progression 
H-positive risk:  702 702 75 1090 399 88 1113 422 163 61 132 53 
H-negative risk:  702 702 1113 1090 422 399 88 75 132 163 53 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
346 
disease_progression 
H-positive risk:  695 698 75 1093 401 88 1113 428 162 60 133 54 
H-negative risk:  698 695 1113 1093 428 401 88 75 133 162 54 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
347 
disease_progression 
H-positive risk:  694 690 73 1091 406 89 1112 434 161 60 132 58 
H-negative risk:  690 694 1112 1091 434 406 89 73 132 161 58 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
348 
disease_progression 
H-positive risk:  689 685 75 1096 399 89 1113 442 160 59 135 58 
H-negative risk:  685 689 1113 1096 442 399 89 75 135 160 58 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
349 
disease_progression 
H-positive risk:  679 677 74 1094 401 90 1117 450 162 59 137 60 
H-negative risk:  677 679 1117 1094 450 401 90 74 137 162 60 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
350 
disease_progression 
H-positive risk:  677 687 74 1093 400 90 1114 447 163 58 139 58 
H-negative risk:  687 677 1114 1093 447 400 90 74 139 163 58 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
351 
disease_progression 
H-positive risk:  684 677 74 1091 406 90 1103 452 162 57 143 61 
H-negative risk:  677 684 1103 1091 452 406 90 74 143 162 61 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
352 
disease_progression 
H-positive risk:  688 673 78 1090 406 90 1101 452 162 57 143 60 
H-negative risk:  673 688 1101 1090 452 406 90 78 143 162 60 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
353 
disease_progression 
H-positive risk:  693 675 78 1088 405 92 1098 447 159 62 143 60 
H-negative risk:  675 693 1098 1088 447 405 92 78 143 159 60 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
354 
disease_progression 
H-positive risk:  698 676 78 1093 402 92 1098 447 153 63 142 58 
H-negative risk:  676 698 1098 1093 447 402 92 78 142 153 58 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
355 
disease_progression 
H-positive risk:  702 672 81 1090 404 91 1101 443 154 67 139 56 
H-negative risk:  672 702 1101 1090 443 404 91 81 139 154 56 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
356 
disease_progression 
H-positive risk:  697 672 82 1094 400 94 1097 454 151 64 141 54 
H-negative risk:  672 697 1097 1094 454 400 94 82 141 151 54 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
357 
disease_progression 
H-positive risk:  697 671 82 1090 401 94 1104 450 152 64 139 56 
H-negative risk:  671 697 1104 1090 450 401 94 82 139 152 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
358 
disease_progression 
H-positive risk:  699 666 83 1086 404 97 1109 444 154 62 140 56 
H-negative risk:  666 699 1109 1086 444 404 97 83 140 154 56 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
359 
disease_progression 
H-positive risk:  702 658 82 1084 411 98 1113 444 151 61 141 55 
H-negative risk:  658 702 1113 1084 444 411 98 82 141 151 55 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
360 
disease_progression 
H-positive risk:  697 662 81 1081 410 97 1111 452 152 60 138 59 
H-negative risk:  662 697 1111 1081 452 410 97 81 138 152 59 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
Time difference of 15.86804 mins
This is task 16
date
